BioCentury
ARTICLE | Financial News

Orexigen adds $60.5 million

October 26, 2012 12:59 AM UTC

Orexigen Therapeutics Inc. (NASDAQ:OREX) raised $60.5 million through the sale of 11 million shares at $5.50 in follow-on underwritten by Credit Suisse; BofA Merrill Lynch; and Leerink. Orexigen is ev...